Safety and Efficacy of DCB Therapy for de Novo Lesions Under the Guidance of QFR in CHD Patients (UNIQUE-DCB-I Study )
In: de la Torre Hernandez JM, Garc Camarero T, Lozano Ru-Poveda F, Urbano-Carrlo CA, Sanchez Perez Cano-Garc M, Saez R, Andres Mort A, Mola E, Par E, Torres A, Lezcano EJ, Gutrrez H, Arnold RJ, Zueco J. Anggraphy and Optal Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTL for the Treatment of -Stent Restenos. Cardvasc Revasc Med. 2020 Apr;21(4):508-513. do 10.1016/j.carrev.2019.07.021. Epub 2019 Jul 23. Rsanen TT, Uskela S, Eranen J, Mantyla P, OllA, Romppanen H, Sjander A, Pta M, Mkken MJ, Tervo J, Karkkaen JM; DEBUT trl vestators. Drug-coated balloon for treatment of de-novo coronary artery lesns patnts wh hh bleedg rk (DEBUT): a sgle-bld, randomed, non-ferry trl. Lancet. 2019 Jul 20;394(10194):230-239. do 10.1016/S0140-6736(19)31126-2. Epub 2019 Jun 13. Erratum : Lancet. 2019 Jul 20;394(10194):218. Bech GJ, Pls NH, De Bruyne B, Peels KH, Mhels HR, Bonnr HJ, Koolen JJ. Usefulness of fractnal flow reserve to predt clal outcome after balloon angplasty. Cculatn. 1999 Feb 23;99(7):883-8. do 10.1161/01.c.99.7.883. Xu B, Tu S, Qo S, Qu X, Chen Y, Yang J, Guo L, Sun Z, LZ, Tn F, Fang W, Chen J, LW, Guan C, Holm NR, Wns W, Hu S. Dgnost Accuracy of Anggraphy-Based Quantate Flow Rat Measurements for Onle Assessment of Coronary Stenos. J Am Coll Cardl. 2017 Dec 26;70(25):3077-3087. do 10.1016/j.jacc.2017.10.035. Epub 2017 Oct 31. Safety and Efficacy of Drug Coated Balloon Therapy for de Novo Lesions in Patients With Coronary Heart Disease Under the Guidance of QFR (UNIQUE-DCB-I Study )
Online
report
| Titel: |
Safety and Efficacy of DCB Therapy for de Novo Lesions Under the Guidance of QFR in CHD Patients (UNIQUE-DCB-I Study )
|
|---|---|
| Link: | |
| Quelle: | de la Torre Hernandez JM, Garc Camarero T, Lozano Ru-Poveda F, Urbano-Carrlo CA, Sanchez Perez Cano-Garc M, Saez R, Andres Mort A, Mola E, Par E, Torres A, Lezcano EJ, Gutrrez H, Arnold RJ, Zueco J. Anggraphy and Optal Coherence Tomography Assessment of the Drug-Coated Balloon ESSENTL for the Treatment of -Stent Restenos. Cardvasc Revasc Med. 2020 Apr;21(4):508-513. do 10.1016/j.carrev.2019.07.021. Epub 2019 Jul 23. Rsanen TT, Uskela S, Eranen J, Mantyla P, OllA, Romppanen H, Sjander A, Pta M, Mkken MJ, Tervo J, Karkkaen JM; DEBUT trl vestators. Drug-coated balloon for treatment of de-novo coronary artery lesns patnts wh hh bleedg rk (DEBUT): a sgle-bld, randomed, non-ferry trl. Lancet. 2019 Jul 20;394(10194):230-239. do 10.1016/S0140-6736(19)31126-2. Epub 2019 Jun 13. Erratum : Lancet. 2019 Jul 20;394(10194):218. Bech GJ, Pls NH, De Bruyne B, Peels KH, Mhels HR, Bonnr HJ, Koolen JJ. Usefulness of fractnal flow reserve to predt clal outcome after balloon angplasty. Cculatn. 1999 Feb 23;99(7):883-8. do 10.1161/01.c.99.7.883. Xu B, Tu S, Qo S, Qu X, Chen Y, Yang J, Guo L, Sun Z, LZ, Tn F, Fang W, Chen J, LW, Guan C, Holm NR, Wns W, Hu S. Dgnost Accuracy of Anggraphy-Based Quantate Flow Rat Measurements for Onle Assessment of Coronary Stenos. J Am Coll Cardl. 2017 Dec 26;70(25):3077-3087. do 10.1016/j.jacc.2017.10.035. Epub 2017 Oct 31. Safety and Efficacy of Drug Coated Balloon Therapy for de Novo Lesions in Patients With Coronary Heart Disease Under the Guidance of QFR (UNIQUE-DCB-I Study ) |
| Medientyp: | report |
| Sonstiges: |
|